CSL Seqirus To Make Bird Flu Vaccine In Holly Springs

By Barry Teater

Global vaccine maker CSL Seqirus has been awarded a $22 million contract by the Biomedical Advanced Research and Development Authority (BARDA) to produce a stockpile of vaccines in case of a bird flu pandemic. The contract requires CSL Seqirus to complete the fill-and-finish process for approximately 4.8 million doses of pre-pandemic vaccine that is well-matched to the currently circulating strain of bird flu virus. This is the fourth contract CSL Seqirus has received from BARDA in response to avian influenza activity. Continue reading to learn about this effort and the company's manufacturing facility in Holly Springs, North Carolina, which is capable of delivering up to 150 million influenza vaccine doses within six months of a pandemic declaration.